DILAZEP
UNII F8KLC2BD5Z

Substance Identification & Data

This profile provides standardized clinical and technical data for Dilazep, uniquely identified by the FDA Unique Ingredient Identifier (UNII) F8KLC2BD5Z.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 35898-87-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

F8KLC2BD5Z

CAS Registry Number

35898-87-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

DILAZEP

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C31H44N2O10

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

QVZCXCJXTMIDME-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C65389

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

3074

Unique identification number in the NCBI database of chemical substances.

INN ID

2779

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1(cc(c(OC)c(c1)OC)OC)C(OCCCN2CCN(CCCOC(c3cc(c(OC)c(c3)OC)OC)=O)CCC2)=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Dilazep. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.